- n a nonsteroidal anti-inflammatory drug (trade name Naprosyn) used in the treatment of arthritis and musculoskeletal inflammation and moderate pain
News & Articles
- FDA panel says data does not support lower heart risk of naproxen
An advisory panel to the U.S. Food and Drug Administration said on Tuesday that available evidence does not prove that the painkiller naproxen, sold under the brand names Aleve and Naprosyn, carries a lower cardiac risk than rival products. The panel was convened after a retrospective analysis from multiple clinical trials published last year in The Lancet suggested naproxen was less dangerous ...
Feb. 11, 2014 - Reuters via Yahoo! News